{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:35:51Z","timestamp":1793414151992,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["MQ484"],"award-info":[{"award-number":["MQ484"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005614","name":"Biogen Inc","doi-asserted-by":"publisher","award":["TW-SPN-11591"],"award-info":[{"award-number":["TW-SPN-11591"]}],"id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.expneurol.2025.115230","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T22:33:17Z","timestamp":1743546797000},"page":"115230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Mechanisms of functional improvement behind nusinersen treatment in adult spinal muscular atrophy"],"prefix":"10.1016","volume":"389","author":[{"given":"Pei-Feng","family":"Hsieh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsing-Jung","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yih-Chih","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Chao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Ya","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Hung","family":"Ting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Ting","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Hsin","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chieh","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsi-Wen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeng-Yi","family":"Shieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Chiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo-Fan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Chin","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Kai","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2025.115230_bb0005","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.nbd.2015.12.014","article-title":"The neuromuscular impact of symptomatic SMN restoration in a mouse model of spinal muscular atrophy","volume":"87","author":"Arnold","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2025.115230_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14102074","article-title":"Clinical and electrophysiological changes in pediatric spinal muscular atrophy after 2 years of Nusinersen treatment","volume":"14","author":"Axente","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.expneurol.2025.115230_bb0015","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1509758112","article-title":"Systemic, postsymptomatic antisense oligonucleotide rescues motor unit maturation delay in a new mouse model for type II\/III spinal muscular atrophy","volume":"112","author":"Bogdanik","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"509\u201332","key":"10.1016\/j.expneurol.2025.115230_bb0020","first-page":"ix","article-title":"Motor unit number estimation in the assessment of performance and function in motor neuron disease","volume":"19","author":"Bromberg","year":"2008","journal-title":"Phys. Med. Rehabil. Clin. N. Am."},{"key":"10.1016\/j.expneurol.2025.115230_bb0025","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1113\/jphysiol.1978.sp012307","article-title":"Sprouting and regression of neuromuscular synapses in partially denervated mammalian muscles","volume":"278","author":"Brown","year":"1978","journal-title":"J. Physiol."},{"key":"10.1016\/j.expneurol.2025.115230_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009802","article-title":"Nerve terminal degeneration is independent of muscle fiber genotype in SOD1G93A mice","volume":"5","author":"Carrasco","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.expneurol.2025.115230_bb0035","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcae267","article-title":"Timing of SMN replacement therapies in mouse models of spinal muscular atrophy: a systematic review and meta-analysis","volume":"6","author":"Chaytow","year":"2024","journal-title":"Brain Commun."},{"key":"10.1016\/j.expneurol.2025.115230_bb0040","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/jcsm.12299","article-title":"Muscle-restricted nuclear receptor interaction protein knockout causes motor neuron degeneration through down-regulation of myogenin at the neuromuscular junction","volume":"9","author":"Chen","year":"2018","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.expneurol.2025.115230_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1294028","article-title":"Nusinersen demonstrates effectiveness in treating spinal muscular atrophy: findings from a three-year nationwide study in Korea","volume":"14","author":"Cho","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.expneurol.2025.115230_bb0050","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1186\/s13023-021-02065-z","article-title":"Motor function in type 2 and 3 SMA patients treated with Nusinersen: a critical review and meta-analysis","volume":"16","author":"Coratti","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.expneurol.2025.115230_bb0055","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/mus.27853","article-title":"Continued benefit of nusinersen initiated in the presymptomatic stage of spinal muscular atrophy: 5-year update of the NURTURE study","volume":"68","author":"Crawford","year":"2023","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.expneurol.2025.115230_bb0060","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa2102047","article-title":"Risdiplam-treated infants with type 1 spinal muscular atrophy versus historical controls","volume":"385","author":"Darras","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2025.115230_bb0065","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/hmg\/ddq514","article-title":"Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice","volume":"20","author":"Dominguez","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2025.115230_bb0070","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11420-005-0124-0","article-title":"EMG: myths and facts","volume":"2","author":"Feinberg","year":"2006","journal-title":"HSS J."},{"key":"10.1016\/j.expneurol.2025.115230_bb0075","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","article-title":"Nusinersen versus sham control in infantile-onset spinal muscular atrophy","volume":"377","author":"Finkel","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2025.115230_bb0080","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/j.nmd.2023.07.094","article-title":"P212 RAINBOWFISH: primary efficacy and safety data in risdiplam-treated infants with presymptomatic spinal muscular atrophy (SMA)","volume":"33","author":"Finkel","year":"2023","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.expneurol.2025.115230_bb0085","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1474-4422(20)30037-5","article-title":"Nusinersen in adults with 5q spinal muscular atrophy: a non-interventional, multicentre, observational cohort study","volume":"19","author":"Hagenacker","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2025.115230_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088739","article-title":"Injection of a soluble fragment of neural agrin (NT-1654) considerably improves the muscle pathology caused by the disassembly of the neuromuscular junction","volume":"9","author":"Hettwer","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.expneurol.2025.115230_bb0095","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/71709","article-title":"A mouse model for spinal muscular atrophy","volume":"24","author":"Hsieh-Li","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.expneurol.2025.115230_bb0100","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nature10485","article-title":"Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model","volume":"478","author":"Hua","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2025.115230_bb0105","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/jnnp-2020-324254","article-title":"Motor unit changes in children with symptomatic spinal muscular atrophy treated with nusinersen","volume":"92","author":"Kariyawasam","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.expneurol.2025.115230_bb0110","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1093\/hmg\/ddx124","article-title":"Motor neuronal repletion of the NMJ organizer, Agrin, modulates the severity of the spinal muscular atrophy disease phenotype in model mice","volume":"26","author":"Kim","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2025.115230_bb0115","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/ana.25168","article-title":"Increase of hyperpolarization-activated cyclic nucleotide-gated current in the aberrant excitability of spinal muscular atrophy","volume":"83","author":"Lai","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2025.115230_bb0120","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","author":"Lefebvre","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2025.115230_bb0125","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/S0140-6736(08)60921-6","article-title":"Spinal muscular atrophy","volume":"371","author":"Lunn","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2025.115230_bb0130","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1136\/jnnp-2020-323822","article-title":"Nusinersen safety and effects on motor function in adult spinal muscular atrophy type 2 and 3","volume":"91","author":"Maggi","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.expneurol.2025.115230_bb0135","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","article-title":"Single-dose gene-replacement therapy for spinal muscular atrophy","volume":"377","author":"Mendell","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2025.115230_bb0140","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJMoa1710504","article-title":"Nusinersen versus sham control in later-onset spinal muscular atrophy","volume":"378","author":"Mercuri","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2025.115230_bb0145","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1126\/science.1250127","article-title":"Motor neuron disease. SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy","volume":"345","author":"Naryshkin","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2025.115230_bb0150","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0092-8674(00)81632-3","article-title":"A novel function for SMN, the spinal muscular atrophy disease gene product, in pre-mRNA splicing","volume":"95","author":"Pellizzoni","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2025.115230_bb0155","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1111\/ene.15005","article-title":"Motor unit number estimation in adult patients with spinal muscular atrophy treated with nusinersen","volume":"28","author":"Schneider","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.expneurol.2025.115230_bb0160","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.yexcr.2005.05.014","article-title":"A role for complexes of survival of motor neurons (SMN) protein with gemins and profilin in neurite-like cytoplasmic extensions of cultured nerve cells","volume":"309","author":"Sharma","year":"2005","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.expneurol.2025.115230_bb0165","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00415-024-12724-3","article-title":"Cytoskeleton dysfunction of motor neuron in spinal muscular atrophy","volume":"272","author":"Shi","year":"2024","journal-title":"J. Neurol."},{"key":"10.1016\/j.expneurol.2025.115230_bb0170","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/s41591-022-01866-4","article-title":"Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the phase III SPR1NT trial","volume":"28","author":"Strauss","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2025.115230_bb0175","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/ana.20473","article-title":"Natural history of denervation in SMA: relation to age, SMN2 copy number, and function","volume":"57","author":"Swoboda","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2025.115230_bb0180","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1001\/archneur.61.11.1669","article-title":"Neuromuscular disorders in severe acute respiratory syndrome","volume":"61","author":"Tsai","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.expneurol.2025.115230_bb0185","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/mt.2014.84","article-title":"Systemic administration of a recombinant AAV1 vector encoding IGF-1 improves disease manifestations in SMA mice","volume":"22","author":"Tsai","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2025.115230_bb0190","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41436-020-00987-w","article-title":"CMAP changes upon symptom onset and during treatment in spinal muscular atrophy patients: lessons learned from newborn screening","volume":"23","author":"Weng","year":"2021","journal-title":"Genet. Med."},{"key":"10.1016\/j.expneurol.2025.115230_bb0195","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.0.CO;2-9","article-title":"An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA)","volume":"15","author":"Wirth","year":"2000","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.expneurol.2025.115230_bb0200","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2300453120","article-title":"Structural insights into the assembly of the grin\/LRP4\/MuSK signaling complex","volume":"120","author":"Xie","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488625000949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488625000949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T04:08:18Z","timestamp":1778040498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488625000949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":40,"alternative-id":["S0014488625000949"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2025.115230","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanisms of functional improvement behind nusinersen treatment in adult spinal muscular atrophy","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2025.115230","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115230"}}